Price Alert

Anebulo Pharmaceuticals I... (ANEB)

NASDAQ: ANEB · Real-Time Price · USD

2.31

-0.09 (-3.75%)

At close: Oct 03, 2025, 3:59 PM

2.31

0.00%

After-hours: Oct 03, 2025, 04:52 PM EDT

Anebulo Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Income	-8.48M	-8.2M	-11.73M	-6.83M	-30.25M
Depreciation & Amortization	382.01K	n/a	n/a	n/a	n/a
Stock-Based Compensation	1.45M	758.88K	884.72K	480.66K	199.95K
Other Working Capital	n/a	-421.14K	-153.72K	637K	-1.56M
Other Non-Cash Items	306.24K	151.23K	731.01K	209.88K	26.63M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	n/a	-799.26K	1.16M	907.78K	-1.45M
Operating Cash Flow	-6.35M	-8.09M	-9.68M	-5.44M	-4.87M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	n/a	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	-201.29K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	14.88M	-62.35K	-264.68K	n/a	-821.63K
Financial Cash Flow	14.88M	-62.35K	6.38M	n/a	21.83M
Net Cash Flow	8.53M	-8.15M	-3.3M	-5.44M	16.96M
Free Cash Flow	-6.35M	-8.09M	-9.68M	-5.44M	-4.87M